Home » Archive

Articles in the Cancidas Category

Cancidas »

Interim Results From A New Trial Of CANCIDAS (caspofungin Acetate) In Pediatric Patients With Documented Fungal Infections
[6 Nov 2009 | No Comment | 13 views]

Cancidas (caspofungin acetate), given once daily, was evaluated as a treatment for patients 3 months to 17 years of age with documented or suspected fungal infections. The use of Cancidas in pediatric patients is investigational. [click link for full article] (Source: Infectious Diseases / Bacteria / Viruses News From Medical News Today)

Cancidas »

Interim Results From A New Trial Of CANCIDAS® (caspofungin Acetate) In Pediatric Patients With Documented Fungal Infections
[6 Nov 2009 | No Comment | 17 views]

Cancidas® (caspofungin acetate), given once daily, was evaluated as a treatment for patients three months to 17 years of age with documented or suspected fungal infections. The use of Cancidas in pediatric patients is investigational. [click link for full article] (Source: Infectious Diseases / Bacteria / Viruses News From Medical News Today)

Cancidas »

Cancidas(Caspofungin Acetate) Injection, Powder, Lyophilized, For Solution [Merck Co., Inc.]
[6 Nov 2009 | No Comment | 16 views]

Updated Date: May 5, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Cancidas »

FDA Approves Expanded Label for CANCIDAS® (caspofungin acetate) as the First and Only Echinocandin Therapy for the Treatment of Pediatric Patients (3 months and older) with Indicated Fungal Infections
[6 Nov 2009 | No Comment | 18 views]

(Source: Merck.com – Product News)

Cancidas »

Now there’s an echinocandin antifungal to treat kids
[6 Nov 2009 | No Comment | 21 views]

Cancidas, previously approved for use in adults, can now be applied also to pediatric patients aged
three months to 17 years. (Source: Drug Topics – Drug Information)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

Cancidas »

Now there’s an echinocandin antifungal to treat kids
[6 Nov 2009 | No Comment | 20 views]

Cancidas, previously approved for use in adults, can now be applied also to pediatric patients aged
three months to 17 years. (Source: Drug Topics – Hot off the Press)

Cancidas »

FDA Approves Expanded Label For CANCIDAS(R) As The 1st And Only Echinocandin Therapy For Pediatric Patients With Indicated Fungal Infections
[6 Nov 2009 | No Comment | 20 views]

Merck & Co., Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Cancidas®, which makes it the first and only echinocandin therapy approved in the United States for the treatment of pediatric patients aged 3 months to 17 years with indicated fungal infections. (Source: Pediatrics News From Medical News Today)

Cancidas »

FDA Approvals: Viread and Cancidas
[6 Nov 2009 | No Comment | 22 views]

The FDA has approved a new indication for tenofovir disoproxil fumarate tablets (Viread) and pediatric indications for caspofungin acetate injection (Cancidas). Medscape Medical News (Source: Medscape Medical News Headlines)

Cancidas »

Cancidas(Caspofungin Acetate) Injection, Powder, Lyophilized, For Solutionfor Intravenous Use [Merck Co., Inc.]
[6 Nov 2009 | No Comment | 11 views]

Updated Date: Sep 11, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Cancidas »

Cancidas (Caspofungin Acetate) – updated on RxList
[6 Nov 2009 | No Comment | 17 views]

Cancidas (Caspofungin Acetate) drug description – FDA approved labeling for prescription drugs and medications at RxList (Source: RxList – New and Updated Drug Monographs)